US$ 26.71
igf 1 lr3 peptide uses IGF-1 1MG Research IGF-1 LR3 – Peptide Foundry
Description
This compound selectively targets the interaction of p53 and Forkhead box protein O 4 (FOXO4) in senescent cells

Specifically, Dp treatment inhibits the increase in ROS levels induced by HO and reduces oxidative damage

Moreover, DAQs can inhibit mitochondrial, lysosomal, autophagy and UPS functions in dopaminergic neurons [12, 60,61,62]

Dosage: 2 ml x 1 pre-filled syringe
